Eagle Bay Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Eagle Bay Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$367K	Sell	6,368 -93	-1%	-$5.34K	0.27%	80
2026 Q1	$392K	Buy	6,461 +166	+3%	+$9.68K	0.35%	70
2025 Q4	$340K	Buy	6,295 +113	+2%	+$5.44K	0.25%	74
2025 Q3	$279K	Sell	6,182 -293	-5%	-$13.7K	0.22%	83
2025 Q2	$300K	Sell	6,475 -11	-0.2%	-$540	0.25%	79
2025 Q1	$396K	Sell	6,486 -32	-0.5%	-$1.86K	0.34%	60
2024 Q4	$369K	Sell	6,518 -199	-3%	-$11.1K	0.23%	70
2024 Q3	$348K	Sell	6,717 -842	-11%	-$39.5K	0.13%	121
2024 Q2	$314K	Sell	7,559 -611	-7%	-$27.3K	0.19%	80
2024 Q1	$443K	Buy	8,170 +425	+5%	+$21.6K	0.28%	61
2023 Q4	$397K	Sell	7,745 -312	-4%	-$16.4K	0.25%	70
2023 Q3	$468K	Buy	8,057 +462	+6%	+$28.3K	0.22%	67
2023 Q2	$486K	Sell	7,595 -492	-6%	-$33K	0.28%	56
2023 Q1	$560K	Buy	8,087 +21	+0.3%	+$1.48K	0.31%	50
2022 Q4	$580K	Sell	8,066 -240	-3%	-$18.1K	0.33%	53
2022 Q3	$591K	Sell	8,306 -400	-5%	-$29K	0.36%	49
2022 Q2	$670K	Buy	8,706 +457	+6%	+$34.8K	0.41%	44
2022 Q1	$602K	Sell	8,249 -188	-2%	-$12.6K	0.49%	33
2021 Q4	$523K	Sell	8,437 -2,089	-20%	-$123K	0.33%	46
2021 Q3	$623K	Buy	10,526 +2,823	+37%	+$186K	0.35%	43
2021 Q2	$518K	Buy	+7,703	New	+$502K	0.42%	36

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Eagle Bay Advisors's BMY Position: Q2 2026 in Review

Eagle Bay Advisors reduced its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, selling an estimated $5.34K and leaving 6,368 shares worth $367K. The position accounts for 0.27% of the portfolio, ranked #80.

Eagle Bay Advisors first reported a position in BMY in Q2 2021 and has held it in 21 quarters since. The position peaked at $670K in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Eagle Bay Advisors held 6,368 shares of Bristol-Myers Squibb worth $367K as of Q2 2026.
Eagle Bay Advisors sold 93 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.34K.
Bristol-Myers Squibb made up 0.27% of Eagle Bay Advisors's portfolio in Q2 2026, its #80 holding.
Eagle Bay Advisors first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 21 quarters since.
Eagle Bay Advisors's Bristol-Myers Squibb position peaked at $670K in Q2 2022.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Eagle Bay Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.